HDFC Pharma and Healthcare IDCW-P
Empty
1–7 yearsInvestment Horizon
HNI,MATarget Segments
Empty
Performance and Risk Analysis
Historical returns, volatility patterns, and how this fund has performed relative to its benchmark.
Risk Profile
Standard Deviation15.4%
Sharpe Ratio1.25
Beta1.01
Strategy Details
A closer look at the investment thesis, portfolio construction, and current holdings.
Portfolio Holdings Overview
SectoralAllocation
Geographic Allocation
Domestic100%
Top Stock Holdings
CompanySectorAllocation
Divi's Laboratories LtdServices9.39%
Sun Pharmaceuticals Industries LtdServices8.28%
Treps - Tri-Party RepoUtilities4.67%
Alkem Laboratories LtdServices4.64%
Cipla LtdServices4.15%
Apollo Hospitals Enterprise LtdServices3.69%
Torrent Pharmaceuticals LtdServices3.65%
Max Healthcare Institute Ltd Ordinary SharesServices3.61%
Aster DM Quality Care Ltd Ordinary SharesServices3.56%
Lupin LtdServices3.55%
Fund House Management
The asset management company’s track record, AUM scale, and fund manager credentials.
Fund Manager Track Record
DM
Dhruv Muchhal
Mr. Dhruv Muchhal has experience of 14 years. Manages 328 funds at HDFC Asset Management Co Ltd with an AUM of approximately ₹4,43,585 Cr Holds a B.Com degree.
26 years
Combined Team Experience
₹ 4,43,585 Cr
Assets Under Management
Operational & Regulatory Details
What it costs to invest, transaction mechanics, and regulatory disclosures you should know.
Costs and Fees
Total Expense Ratio (TER)2.16%
Regulatory & Tax Information
INF179KC1HM5
ISINDailyDealing Frequency
BSE Healthcare PR INRBenchmark
LTCG | >1Year 12.5%% on gain above 1.25 Lakh
STCG | <1Year 20%%
Tax Implications (India)